Global Femoral Cannula Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Femoral arteriovenous cannula provides temporary support for extracorporeal circulation and gas exchange to replace heart or lung function as a bridge for resuscitation or other long-term support.
When intubated through the femoral and internal jugular veins, blood is drawn through the femoral or internal jugular vein catheter and pumped through membrane oxygenators to remove carbon dioxide, increase oxygen, and provide temperature control.
Partial to complete extracorporeal lung support is provided to maintain adequate oxygenation and normal blood flow.
According to our (Global Info Research) latest study, the global Femoral Cannula market size was valued at US$ 38.2 million in 2023 and is forecast to a readjusted size of USD 55.6 million by 2030 with a CAGR of 5.6% during review period.
Globally, major manufacturers of femoral arteriovenous systems include Medtronic, Edward Lifescience, LivaNova, Surge Cardiovascular, Kangxin, Xenios AG, and Chalice Medical.
The main producers are mainly in Europe and the United States.
This report is a detailed and comprehensive analysis for global Femoral Cannula market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Femoral Cannula market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Femoral Cannula market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Femoral Cannula market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Femoral Cannula market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Femoral Cannula
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Femoral Cannula market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Edward Lifescience, LivaNova, Surge Cardiovascular, Changzhou KangXin Medical Instruments Co., Ltd., Chalice Medical Ltd., Xenios AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Femoral Cannula market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Unipolar
Bipolar
Market segment by Application
Traditional extracorporeal circulation surgery
Extracorporeal membrane oxygenation (ECMO)
Hemodialysis
Other
Major players covered
Medtronic
Edward Lifescience
LivaNova
Surge Cardiovascular
Changzhou KangXin Medical Instruments Co., Ltd.
Chalice Medical Ltd.
Xenios AG
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Femoral Cannula product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Femoral Cannula, with price, sales quantity, revenue, and global market share of Femoral Cannula from 2019 to 2024.
Chapter 3, the Femoral Cannula competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Femoral Cannula breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Femoral Cannula market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Femoral Cannula.
Chapter 14 and 15, to describe Femoral Cannula sales channel, distributors, customers, research findings and conclusion.